BEVERLY HILLS, CA--(Marketwired - Mar 21, 2017) - Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) ("Rich" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, announced today that it has reached agreement with I Tech Health Corp. to form a subsidiary and launch CannCodex to serve the Medicinal Cannabis industry as well as provide data and services to pharmaceutical companies worldwide.
March 21, 2017 at 12:08PM
http://ift.tt/2n2J396
from
http://ift.tt/2n2J396
No comments:
Post a Comment